Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis.

Under various conditions, mammals have the ability to maintain serum glucose concentration within a narrow range. SIRT1 plays an important role in regulating gluconeogenesis and fat metabolism; however, the underlying mechanisms remain elusive. Here, we show that SIRT1 forms a complex with FOXO3a and NRF1 on the SIRT6 promoter and positively regulates expression of SIRT6, which, in turn, negatively regulates glycolysis, triglyceride synthesis, and fat metabolism by deacetylating histone H3 lysine 9 in the promoter of many genes involved in these processes. Liver-specific deletion of SIRT6 in mice causes profound alterations in gene expression, leading to increased glycolysis, triglyceride synthesis, reduced beta oxidation, and fatty liver formation. Human fatty liver samples exhibited significantly lower levels of SIRT6 than did normal controls. Thus, SIRT6 plays a critical role in fat metabolism and may serve as a therapeutic target for treating fatty liver disease, the most common cause of liver dysfunction in humans.

[1]  Min You,et al.  Adiponectin and alcoholic fatty liver disease , 2008, IUBMB life.

[2]  D. Rader,et al.  Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. , 1999, Journal of lipid research.

[3]  L. Guarente,et al.  The Sir2 family of protein deacetylases. , 2004, Annual review of biochemistry.

[4]  C. Deng.  SIRT1, Is It a Tumor Promoter or Tumor Suppressor? , 2009, International journal of biological sciences.

[5]  K. Ohbuchi,et al.  Hepatic De Novo Lipogenesis Is Present in Liver-Specific ACC1-Deficient Mice , 2007, Molecular and Cellular Biology.

[6]  Or Gozani,et al.  Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6 , 2009, Cell cycle.

[7]  Bo Yang,et al.  The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability , 2009, Cell cycle.

[8]  D. Crabb,et al.  The role of AMP-activated protein kinase in the action of ethanol in the liver. , 2004, Gastroenterology.

[9]  G. Marsicano,et al.  Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. , 2008, Cell metabolism.

[10]  L. Guarente,et al.  Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. , 2006, Genes & development.

[11]  Hashimoto Takashi,et al.  Effects of administration of di-(2-ethylhexyl)phthalate on rat liver mitochondria. , 1978 .

[12]  J. Yates,et al.  A Fasting Inducible Switch Modulates Gluconeogenesis Via Activator-Coactivator Exchange , 2008, Nature.

[13]  S. Nemoto,et al.  Nutrient Availability Regulates SIRT1 Through a Forkhead-Dependent Pathway , 2004, Science.

[14]  D. Reinberg,et al.  SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation , 2007, Nature.

[15]  L. Guarente,et al.  Mouse Sir2 Homolog SIRT6 Is a Nuclear ADP-ribosyltransferase* , 2005, Journal of Biological Chemistry.

[16]  B. Thiers.  Genomic Instability and Aging-like Phenotype in the Absence of Mammalian SIRT6 , 2007 .

[17]  E. Verdin,et al.  Sirtuins: critical regulators at the crossroads between cancer and aging , 2007, Oncogene.

[18]  C. Deng,et al.  Direct removal in the mouse of a floxed neo gene from a three‐loxp conditional knockout allele by two novel approaches , 2001, Genesis.

[19]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Deng,et al.  Interplay among BRCA1, SIRT1, and Survivin during BRCA1-associated tumorigenesis. , 2008, Molecular cell.

[21]  R. de Cabo,et al.  Regulation of SIRT6 protein levels by nutrient availability , 2008, FEBS letters.

[22]  Steven P Gygi,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. , 2005, Nature.

[23]  J. Girard,et al.  Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. , 2008, The Journal of clinical investigation.

[24]  L. Guarente,et al.  Genetic pathways that regulate ageing in model organisms , 2000, Nature.

[25]  J. Romijn,et al.  Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models. , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Shiwei Song,et al.  A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis , 2008, Proceedings of the National Academy of Sciences.

[27]  H. Broxmeyer,et al.  Sirtuin 1, stem cells, aging, and stem cell aging , 2008, Current opinion in hematology.

[28]  X. Wang,et al.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. , 2008, Cancer cell.

[29]  Delin Chen,et al.  Mammalian SIRT1 Represses Forkhead Transcription Factors , 2004, Cell.

[30]  Howard Y. Chang,et al.  SIRT6 Links Histone H3 Lysine 9 Deacetylation to NF-κB-Dependent Gene Expression and Organismal Life Span , 2009, Cell.

[31]  Karen Usdin,et al.  NF-Y, AP2, Nrf1 and Sp1 regulate the fragile X-related gene 2 (FXR2). , 2006, The Biochemical journal.

[32]  Howard Y. Chang,et al.  SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin , 2008, Nature.

[33]  Lulu Chen,et al.  The expression of SIRT1 in nonalcoholic fatty liver disease induced by high‐fat diet in rats , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[34]  Emilio Clementi,et al.  Calorie Restriction Promotes Mitochondrial Biogenesis by Inducing the Expression of eNOS , 2005, Science.

[35]  A. Alpi,et al.  Characterization of two Arabidopsis thaliana fructokinases. , 2001, Plant science : an international journal of experimental plant biology.

[36]  Qing Xu,et al.  Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. , 2009, Cell metabolism.

[37]  C. Deng,et al.  SIRT3 interacts with the daf-16 homolog FOXO3a in the Mitochondria, as well as increases FOXO3a Dependent Gene expression , 2008, International journal of biological sciences.

[38]  D. B. Lombard,et al.  SIRT6 in DNA repair, metabolism and ageing , 2008, Journal of internal medicine.

[39]  P. Puigserver,et al.  Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1 , 2007, Proceedings of the National Academy of Sciences.

[40]  F. Alt,et al.  Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Byrne,et al.  Current treatment of non‐alcoholic fatty liver disease , 2009, Diabetes, obesity & metabolism.

[42]  C. Deng,et al.  Recent progress in the biology and physiology of sirtuins , 2009, Nature.

[43]  Steven P. Gygi,et al.  Stress-Dependent Regulation of FOXO Transcription Factors by the SIRT1 Deacetylase , 2004, Science.

[44]  Orian S. Shirihai,et al.  The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α , 2010, Cell.

[45]  C. Deng,et al.  SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. , 2010, Cancer cell.